Drug Safety Trends in the Hypertrophic Cardiomyopathy Therapeutics Market
The global hypertrophic cardiomyopathy (HCM) therapeutics market was valued at USD 1.4 billion in 2025 and is expected to reach USD 1.5 billion in 2026. The market is forecast to expand to USD 2.2 billion by 2033, representing a 5.5% CAGR from 2026 to 2033. North America led the global market in 2025, accounting for 45.6% of total revenue. Market...
0 Comments 0 Shares 57 Views 0 Reviews